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Poor dietary choices are major risk factors for obesity and non-communicable diseases,
which places an increasing burden on healthcare systems worldwide. To monitor the
effectiveness of healthy eating guidelines and strategies, there is a need for objective
measures of dietary intake in community settings. Metabolites derived from specific foods
present in urine samples can provide objective biomarkers of food intake (BFIs). Whilst the
majority of biomarker discovery/validation studies have investigated potential biomarkers
for single foods only, this study considered the whole diet by using menus that delivered
a wide range of foods in meals that emulated conventional UK eating patterns. Fifty-one
healthy participants (range 19–77 years; 57% female) followed a uniquely designed,
randomized controlled dietary intervention, and provided spot urine samples suitable
for discovery of BFIs within a real-world context. Free-living participants prepared and
consumed all foods and drinks in their own homes and were asked to follow the protocols
for meal consumption and home urine sample collection. This study also assessed the
robustness, and impact on data quality, of a minimally invasive urine collection protocol.
Overall the study design was well-accepted by participants and concluded successfully
without any drop outs. Compliance for urine collection, adherence to menu plans, and
observance of recommended meal timings, was shown to be very high. Metabolome
analysis using mass spectrometry coupled with data mining demonstrated that the study
protocol was well-suited for BFI discovery and validation. Novel, putative biomarkers for
an extended range of foods were identified including legumes, curry, strongly-heated
products, and artificially sweetened, low calorie beverages. In conclusion, aspects of this
study design would help to overcome several current challenges in the development of
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BFI technology. One specific attribute was the examination of BFI generalizability across
related food groups and across different preparations and cooking methods of foods.
Furthermore, the collection of urine samples at multiple time points helped to determine
which spot sample was optimal for identification and validation of BFIs in free-living
individuals. A further valuable design feature centered on the comprehensiveness of
the menu design which allowed the testing of biomarker specificity within a biobank of
urine samples.
Keywords: dietary intake, metabolomics, free-living participants, biomarkers, radomized control trial
INTRODUCTION
The amount and pattern of foods and beverages consumed
influence gene expression (1) and are major determinants of
multiple health outcomes (2). Despite this centrality in the
atiology of health and disease, the estimation of habitual
dietary intake remains difficult (3). Conventional tools based
on dietary self-report are tedious and time-consuming for
both study participants and researchers. Dietary misreporting is
common and substantial (4) and is exacerbated in those who
are overweight or obese (5). Whilst the development of digital
tools to assist with dietary recording may reduce the workload
for respondents and researchers (6), use of such tools does not
eliminate the subjectivity and biases inherent in approaches based
on self-report. To improve measurements of dietary intake, there
is a need to develop strategies for the objective identification,
validation and deployment of suitable biomarkers (7).
Biomarkers of food intake (BFIs) assessed in body fluids
or easily-accessible tissues offer potential alternative, objective
routes to estimating dietary exposure (8). Measurement of BFIs
(9, 10) could overcome some of the limitations of traditional
dietary assessment methodologies by providing additional
objective estimates of food exposure (11). Such biomarkers
are of two main types: (i) those biomarkers which attempt
to estimate a major class of nutrients e.g., urinary nitrogen
excretion as an index of dietary protein consumption (12) and
(ii) biomarkers which attempt to estimate intake of specific foods
or food constituents (13). Most foods contain large numbers
of characteristic metabolites many of which are cataloged in
comprehensive databases of food composition, e.g., FoodB
(developed by the University of Alberta, Canada: www.foodb.
ca) and of selected food components, e.g., Phenol Explorer
Abbreviations: AGC, Automatic gain control; AUC, area under the Receiver
Operator Characteristic curve; BFI, biomarker of food intake; BMI, Body
Mass Index; CRN, Clinical Research Network; EPIC, European Prospective
Investigation into Cancer and Nutrition; FFQ, food frequency questionnaire; FIE-
HRMS, flow infusion electrospray ionization—high resolution mass spectrometry;
FMV, first morning void; HCD, Higher-energy collision dissociation; IPAQ,
International Physical Activity Questionnaire; ISRCTN, International Standard
Randomized Controlled Trial Number; MAIN, Metabolomics at Aberystwyth,
Imperial andNewcastle; MDS,Multi-dimensional scaling;MRC,Medical Research
Council; MS, mass spectrometry; MSI, Metabolomics Standards Initiative; MSn,
Tandem mass spectrometry; NDNS, National Diet and Nutrition Survey; PA,
physical activity; RF, Random Forest; ROC, Receiver Operator Characteristic;
SD, Standard deviation; TMAO, Trimethylamine-N-oxide; UHPLC-HRMS, Ultra
High Performance Liquid Chromatography-High Resolution MS.
(developed by INRA: www.phenol-explorer.eu). However, when
foods are consumed, they undergo metabolic transformation
during digestion and absorption by enterocytes and colonocytes,
by bacteria within the gut lumen and by Phase 1 and Phase
2 enzymes within the liver. Therefore, although the patterns
of metabolites present in blood or urine reflect what has been
consumed, the specific metabolites in such body fluids may differ
substantially from those ingested (14).
We, and others, have applied metabolomics approaches to
blood, saliva and urine in human studies to discover novel BFIs
(8, 15–22). We have focused on urine as the body fluid of choice
because of the ease of collection and the fact that, in contrast
with blood, it provides an integrated estimate of exposure over
several hours and because of technical advantages in sample
preparation for metabolomics assay (8). This has led to the
identification of a substantial number of putative biomarkers
of individual foods (23) and to potential biomarkers of the
overall healthfulness of the diet (24). Consensus guidelines for the
critical assessment of candidate BFIs have been proposed recently
(10). Although valuable, these guidelines focused on qualifying
the utility of individual BFIs to monitor exposure to specific
foods/food groups. Food intervention studies to determine the
impact of individual dietary components on health form a
large component of nutrition research but equally important
is the need for approaches to assess overall dietary exposure
in epidemiological studies and clinical trials (24). Whilst these
discoveries and developments are encouraging, several challenges
remain, associated particularly with the deployment of BFI
technology in real world settings (Table 1).
The MAIN (Metabolomics at Aberystwyth, Imperial and
Newcastle) Study was designed to address these challenges by
investigating biomarkers of food intake under conditions in
which study participants consumed well-characterized foods
within conventional diets with respect to meal design, cooking
and eating patterns and collected urine samples at home without
changing their usual behavior. This provided an opportunity to
expand biomarker coverage to include a more comprehensive
range of foods and beverages that are highly consumed in the UK
and considered important for the UK government healthy eating
policy (25). Our primary aim was to develop protocols which
could be applied in large-scale epidemiological studies, clinical
trials and in public health surveys. We focused on approaches
that would be acceptable to the public, easy to follow and to
adhere to, and which would be of modest cost. In this paper,
we report the detailed design and protocol of the MAIN Study
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TABLE 1 | Challenges associated with the design of a food intervention study to develop and assess deployment of BFI technology to monitor overall dietary exposure.
(1) Providing opportunity to expand the discovery of biomarkers to include as many commonly-consumed foods as possible
(2) Ensuring structured exposure to a sufficiently comprehensive range of foods to mimic diets typical of a specific population
(3) Validating biomarker specificity in real world settings using conventional eating patterns where a whole diet is consumed rather than focusing on single food items
(4) Evaluating the impact of food preparation/processing/formulation and cooking method on the behavior of biomarkers of specific foods
(5) Developing a urine sampling strategy that enables collection of samples with minimal burden on free-living participants and without adversely affecting the quality
and comprehensiveness of biomarker measurement
conducted at Newcastle University (MAIN Study Newcastle) as
well as baseline characteristics of participants recruited to the
study. Elsewhere we have reported the validation of the urine
sampling methodology for free-living study participants showing
it was non-intrusive, imposed low participant burden, and
delivered samples with high quality metabolome content assessed
using metabolite fingerprinting (26, 27). Here, we include a
summary of novel biomarkers discovered using samples from the
MAIN Study with the aim of extending the BFI coverage to a
wider range of commonly consumed foods.
MATERIALS AND METHODS
Ethics Approval and Consent to Participate
The studies involving human participants were approved
by East Midlands—Nottingham 1 National Research Ethics
Committee (14/EM/0040) following Proportionate Review.
Caldicott approval for storage of data and data protection was
granted by Newcastle-upon-Tyne Hospitals NHS Foundation
Trust [6896(3109)]. The trial was adopted into the UK Clinical
Research Network (CRN) Portfolio (16037) and was registered
with International Standard Randomized Controlled Trial
Number (ISRCTN), 88921234.
A study information sheet was given to all potential
participants in advance of their first visit to the research
unit. The participants provided written informed consent to
participate in each study, taken by an appropriately trained
researcher. All procedures performed in studies involving human
participants were in accordance with the ethical standards of
the institutional and/or national research committee and with
the 1964 Helsinki declaration and its later amendments or
comparable ethical standards.
Participant Recruitment
Participants were recruited using the inclusion criteria in
Supplementary Table 1 through poster and leaflet campaigns
around Newcastle University campus and in local public
buildings e.g., libraries. In addition, invitation letters were
sent to potential participants who had registered their interest
with Newcastle University in being contacted about upcoming
nutrition-related studies. An advertisement for the study was also
placed in a local newspaper. Some participants were recruited by
word of mouth.
Based on data from our earlier studies (28), we aimed for a
sample size of 15 participants for Study 1 (which incorporated
experimental period 1 menu plans) and 30 participants for Study
2 (which incorporated experimental period 2 menu plans)—
this allowed for a 20% drop out. To minimize the risk that
current disease ormedications used for their management altered
metabolism and, therefore, compromised the normal behavior
of food-related biomarkers detected in urine, we implemented
an a priori exclusion list (Supplementary Table 1). For similar
reasons, we excluded potential participants who reported that
they had had a cholecystectomy or who undertook a high level of
exercise such as a professional athlete or body builder. Vegetarian
recruits had to be willing to eat meat and fish during the studies.
Intervention Design and Randomisation
The MAIN Study Newcastle was built around six daily menu
plans, delivered in two separate, 3-day experimental periods.
Menu plans 1–3 constituted experimental period 1; menu
plans 4–6 constituted experimental period 2. Menu plans were
designed to emulate real world conditions and to reflect the whole
diet by including many commonly-eaten foods in the context of a
typical UK diet. All foods and drinks were provided to free-living
individuals who prepared and consumed the meals in their own
homes/places of work and were responsible for collecting urine
samples while carrying out their normal daily activities.
Experimental period 1 menus were based largely on foods
for which a significant amount of metabolite-based biomarker
research has been published. The menus permitted the provision
of 4–5 target foods each day, providing opportunity for
biomarker validation as described in Lloyd et al. (27). On the
first experimental day, participants consumed test foods for
which there were some previously published urinary metabolite
biomarkers while, on the two subsequent experimental days,
they consumed foods for which putative biomarkers have been
proposed but for which further validation and/or discovery is
necessary. This first experimental period allowed the refinement
of a spot urine sampling protocol for use in real world settings.
Participants collected a range of post-prandial spot urines,
which were compared for chemical richness and evaluated
for the presence of known and putative dietary biomarkers.
The overarching aims of this part of the study were to: (i)
identify the urine collection times which provided the most
data-rich spot urine for accurate capture of biomarker behavior
relating to recent dietary intake and (ii) develop acceptable, non-
onerous and easy-to-implement urine sampling protocols for the
future identification and validation of novel biomarkers of foods
included within the menus [see Lloyd et al. (27) andWilson et al.
(29) for further detail].
To assess whether use of a standardized evening meal
[as employed in our earlier studies (30)] was advantageous
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for “normalizing” urines prior to biomarker validation and
discovery, participants followed these menus in the same order
on 2 separate weeks. Participants were randomized to either a
standardized evening meal (chicken casserole ready meal and
chocolate éclair) or a low polyphenol evening meal of their
choice, to be eaten immediately before the experimental period.
Participants were provided with a guide to high polyphenol
foods/drinks that they should not eat/avoid and a list of low
polyphenol foods/drinks which they should select from during
the “Pre” day (see Figure 1). A cross-over design was employed
so that all participants underwent both dietary interventions
i.e., standardized evening meal and own choice low polyphenol
evening meal.
Experimental period 2 menu plans were designed to
identify novel biomarkers of food intake and to investigate
whether the putative urinary biomarkers for specific foods were
influenced by food preparation, processing, quality, formulation,
complexity, and cooking method. Menus were created to deliver
foods for which there were few, uncertain or no published
biomarkers. In addition, we expanded the range of food
formulations investigated in experimental period 1. For example,
red and white grapes were included in the following forms:
whole grapes, raisins (dried), wine (fermented), grape juice
(pasteurized/heat-treated/concentrated), sparkling grape juice
(carbonated drink), and a fruit smoothie (complex beverage).
Whole grains were delivered across both experimental periods
in the form of rye bread (with and without a sourdough
starter, toasted and untoasted), wholemeal bread (toasted and
untoasted), wholegrain breakfast cereal (Weetabix R©), porridge
oats (boiled/microwaved with milk) and wholemeal pasta
(extruded). Participants consumed a range of commonly eaten
foods in three different daily menu plans, which were presented
in a different order in each of three experimental weeks. This
design facilitated the search for novel biomarkers of specific
foods, but also provided the potential to characterize the kinetics
of biomarker appearance and decay and to investigate the
longevity of biomarker signals in urine.
Each daily menu plan was designed to emulate conventional
UK eating patterns with a breakfast, lunch, afternoon snack
and dinner. All foods and drinks for the whole intervention
were provided to participants in appropriate portion sizes and
with cooking instructions, where necessary. Participants were
encouraged to consume these items to the exclusion of any
other foods or beverages, but had the freedom to eat or not the
meals and to interpret the cooking instructions as they wished.
During each experimental week, the allocated menu plans were
followed from Tuesday to Thursday, as shown in Figure 1.
Experimental period 1 menu plans were eaten in the same order
on 2 consecutive weeks (Study 1); experimental period 2 menu
plans were eaten in pre-determined orders over a 3-week period
(Study 2). In each experimental week, the “Pre” day was the day
before starting the experimental period and was always aMonday
and included a pre-determined evening meal (Dinner). The
“Post” day was the day following completion of the experimental
period when the last biological samples were collected and was
always a Friday. Participants visited the Clinical Aging Research
Unit, Newcastle University on these 2 days only. This design
minimized the number of trips the participants had to make to
the University and also enabled participants to take a break from
the studies at weekends, so reducing the burden of compliance.
During the “Pre” day, participants were asked to restrict, as far
as possible, their polyphenol intake. In practical terms, this meant
reducing their intake of brightly colored fruits and vegetables,
chocolate, tea, herbal teas and coffee. Participants were asked to
abstain from alcohol and stop taking any dietary supplements
for the duration of the studies. In Study 1, dinner on the “Pre”
day was either a standardized evening meal or a low polyphenol
meal of the participant’s choice whilst in Study 2 it consisted of
one of three meals designed to capture biomarkers of relatively
unhealthy food choices, particularly poorer-quality meats and
breaded and battered foods.
Menu plans were developed using Public Health England
policy advice from The Eatwell Plate which has been revised as
The Eatwell Guide (25) and information on the eating habits
of the British population which were collected and collated in
the National Diet and Nutrition Survey (NDNS), years 1–3 (31).
The process of menu plan design has been described in detail
in a recent publication (27). Briefly, this involved analysis of
each food grouping described in the Eatwell Plate (e.g., fruit
& vegetables) and investigating the disaggregated food groups
that contribute to that food grouping in the NDNS (e.g., fresh
& canned fruit; fruit juice; dried fruit etc.). We then identified
the most commonly eaten foods within each disaggregated
food group and incorporated as many as possible of the most
commonly consumed foods into the menu plans using the most
commonly reportedmethod of preparation (e.g., raw/boiled/with
or without skin). To assess biomarker robustness, multiple
forms of similar foods using different processing methods and
formulations were delivered as discrete meal components and
incorporated within complex meals, and using different cooking
methods. Foods and portion sizes were compatible with normal
eating behavior and were provided according to conventional UK
daily meal patterns using commercially available foods. We used
average (medium) portions of each food as determined by the
Food Standards Agency “Food Portion Sizes” Guide (32). Exact
amounts of each food provided has been described elsewhere
(26, 27). An example daily menu plan from experimental period
2 is shown in Supplementary Table 2.
To identify the easiest to collect and most informative spot
urine sample, participants were asked to collect several spot
urine samples each day. These included their first morning
void (FMV) before breakfast; a fasting sample, defined as a
sample collected after the FMV but before breakfast, following
an overnight fast of at least 12 h; a sample collected any time
between finishing breakfast and eating lunch and a sample
collected any time between finishing lunch and eating their
afternoon snack. Each urination between dinner and the FMV
the following day was also collected. To reduce variation in
timing of urine sample collection, participants were encouraged
to consume meals within a 2 h time slot (breakfast, lunch and
dinner) or 30min time slot (afternoon snack) as illustrated in
Figure 1. However, the participants were free to ignore this
advice and to provide a urine sample at the time most convenient
for them.
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FIGURE 1 | The MAIN Study timeline. Participants were asked to follow a low polyphenol diet prior to starting the experimental period. Where applicable, dinner was
provided on the “Pre” day (Monday). All foods and drinks for 3 consecutive experimental days (Tuesday, Wednesday, and Thursday) were provided. Participants
collected first morning void (FMV), fasting urines and spot urines post-breakfast and post-lunch each day during the experimental period, and a FMV and fasting urine
on the “Post” day. Any urination between finishing dinner and providing the FMV the following day was also collected. A fasting blood sample was taken on the “Post”
day only. Figure adapted from Lloyd et al. (27).
Participants were encouraged to keep hydrated and to drink
water ad libitum. To help maintain good hydration, participants
were given eight 500ml bottles of water per experimental week,
one to be drunk with/after each dinner, one to be drunk during
each experimental day and one to be drunk on the morning of
the “Post” day, prior to venipuncture.
Participants in Study 1 were randomized (random.org) at
enrolment to one of two dinner options on the “Pre” day. In Study
2, participants were randomized to one of 12 3× 3 Latin squares
(3 daily menu plans × 3 experimental weeks) at enrolment. The
order in which these participants consumed the three less healthy
dinners on the “Pre” day in each of the three experimental weeks
was randomized independently.
Compliance
Dietary compliance was assessed by participant self-report. They
were asked to record how much of each food/drink item they
ate. If some food was uneaten, the participant recorded the
amount eaten as 75, 50, 25% or 0, as appropriate. Dietary
substitutions, intrusions and protocol deviations were also
recorded. Participants recorded if they substituted any foods or
drinks of their own choosing for those provided by the research
team, ate or drank any additional items or prepared any of the
meals differently from that instructed.
A 1-day food diary was used to record all foods and drinks
consumed from 8pm on the evening before and throughout the
“Pre” day. This was used to check participant compliance with the
low polyphenol diet prior to commencement of the experimental
period each week.
To monitor compliance with both the urine collection
protocol and suggested meal times, participants completed a
Urine sample collection record and a Meal time record—
the latter asked specifically at what time they finished eating
each meal. This acted as a check on the accuracy of the
FMV and fasting urine samples collected. In addition, this
information allowed calculation of the time interval between
meal consumption and subsequent urine collections.
Study Measures
Information on participant socio-demographics (age, sex,
smoking status, and alcohol consumption), medical history,
current medications, and use of dietary supplements was
collected at enrolment.
In Study 1, weight, height and waist circumference were
measured on “Pre” and “Post” days of each experimental week.
In Study 2, height and waist circumference were recorded in
week 1 only, whilst weight was recorded weekly, pre- and post-
the experimental period. All anthropometric measurements were
made at the research unit by the same researcher.
Body weight was measured to the nearest 0.1 kg using a Tanita
body composition analyzer (TBF-300MA; Tanita Corporation,
Tokyo, Japan); height was measured to the nearest 0.1 cm using
a Leicester portable height measure (Chasmors Ltd, London,
UK). Waist circumference (at the point equidistant between
the costal margin and the iliac crest) was measured to the
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nearest 0.1 cm using a non-stretch tape measure over bare skin,
whenever possible. Waist circumference measurements were
taken in duplicate, or repeated until two measurements agreed
within 1 cm. Participants were asked to wear lightweight clothing
and removed their shoes for all measurements.
Habitual dietary intake was assessed at the beginning of each
study using a locally adapted version of the validated food
frequency questionnaire (FFQ) used in the European Prospective
Investigation into Cancer and Nutrition (EPIC) (33).
Tomonitor their physical activity (PA), each week participants
were asked to complete the International Physical Activity
Questionnaire (IPAQ) short form (34).
Blood and Urine Sample Collection
Participants collected urine samples at suggested times (Figure 1)
in a calibrated plastic jug and recorded the date, time and total
volume of collection. A 20ml aliquot from each urination was
retained and the rest discarded. If not at home, participants
kept urine samples in a cool bag containing a frozen cool block,
otherwise they stored them in a refrigerator before returning
them to the research team at the end of each experimental week.
It has been reported that no major changes in urinary metabolite
fingerprints occur when samples are stored in tubes held at+4◦C
for up to 72 h (35). We have shown recently that the metabolome
of spot urine samples collected, stored and transported as
described in this manuscript is stable with negligible microbial
growth at 4◦C and, specifically, that inclusion of preservatives
has no impact on data quality (36). For long-term storage,
urine samples were divided into 10 × 1ml aliquots [2ml screw-
cap microtubes (Starstedt, Germany)] which were free from
plasticisers (in house tests; data not shown)] and 1 × 5–10ml
aliquot (25ml Universal tubes; Starstedt) and stored at−80◦C.
Whole blood, serum and plasma were archived at −80◦C
for future lipidomic analysis and associated metabolite
fingerprinting. Venipuncture was performed on the “Post”
day of each week after a minimum 12 h overnight fast. After
filling, blood tubes were inverted several times, kept flat on ice
and processed within 2 h. Before processing, the height of the
blood in each tube was recorded to assess filling. Plasma was
separated from anti-coagulated blood collected in 1× EDTA and
2× lithium/heparin Vacutainer R© blood collection tubes (Becton
Dickinson, Oxford, UK) by centrifugation at 3,100× g for 5min
at 4◦C in a Jouan CR3i centrifuge (Saint-Herblain, France).
Plasma was stored at −80◦C in 1ml aliquots in plasticiser-free
microtubes as described above. Serum was separated from
coagulated blood collected in 2 × gel Vacutainer R© tubes at least
30min after collection, aliquoted and stored as for plasma. One
tube of unprocessed whole blood, collected in an EDTA-coated
tube, was also stored at−80◦C.
A summary of the time points at which key data,
measurements and biological samples were collected is given in
Table 2 (Study 2) and Supplementary Table 3 (Study 1).
Metabolomic Analysis
The metabolomics methods implemented for biomarker
discovery have been published elsewhere (26, 27). All urine
samples were normalized by refractive index prior to analysis
to ensure all MS measurements were made within a similar
dynamic range. Essentially, urine samples were analysed by non-
targeted metabolite fingerprinting using high resolution (HR)
flow infusion electrospray (FIE) ionization mass spectrometry
(MS), acquired on an Exactive Orbitrap (ThermoFinnigan,
San Jose, CA) mass spectrometer coupled to an Accela
(ThermoFinnigan) ultra-performance liquid chromatography
system. Supervised Random Forest (RF) classification was
implemented to investigate the presence of distinctive urine
composition changes following consumption of specific meals.
A combination of accuracy, margins of classification and
area under the ROC (Receiver Operator Characteristic) curve
(AUC) were used to evaluate the performance of classification
models (37). To reveal potential explanatory signals responsible
for discriminating between baseline and post-prandial urine
samples, a combination of RF, AUC and Student’s t-test was
employed for feature selection (37).
The methodology used for biomarker identification has been
described in detail elsewhere (26, 27). For metabolite signal
annotation, accurate m/z values were extracted for high-ranked
explanatory signals and queried using MZedDB, an interactive
accurate mass annotation tool (38). Ultra High Performance
Liquid Chromatography-High Resolution MS (UHPLC-HRMS)
and Tandemmass spectrometry (MSn) allowed further structural
identification of putative biomarkers as previously described
(39). Refractive index adjusted urine samples were diluted with
100% MeOH (1:1, v:v) and centrifuged at 1,400 × g for 5
mins at 4◦C. Samples were analysed on an Orbitrap Fusion
Tribrid mass spectrometer (Thermo Scientific, Waltham, MA)
coupled to a Dionex Ultimate 3000 Ultra High Performance
Liquid Chromatography (UHPLC) system (Thermo Scientific).
Chromatographic separation was performed on a reverse phase
(RP) Hypersil Gold 1.9µm, 2.1 × 150mm column (Thermo
Scientific) using 0.1% formic acid in H2O (mobile phase A) and
0.1% formic acid in MeOH (mobile phase B) at a flow rate of 0.6
ml/min and column oven temperature at 60◦C. Each sample (5
µl) was analysed by following a gradient after 0.5min isocratic
A to 40 % B in 3.5min and subsequently to 100% in 5min. The
column was washed with 100% B for 2.5min and re-equilibrated
for 2.5min. Data were acquired in two runs using respective
positive and negative ESI mode. Each experiment consisted
of a full scan [110–1,100 m/z at 120,000 resolution and MS2
scans (ddMS2 OT HCD event, stepped Higher-energy collision
energies of 45, 60, 75%) and 15,000 Orbitrap mass resolution]
within a 1 s cycle time using selected targeted mass properties
for either positive or negative ionization mode between 1 and
12min runtime. The maximum injection time was 22ms and
the Automatic Gain Control (AGC) target of 1 × 104 was set
to be exceeded if there is parallelisable time. The spray voltage
was 3.5 kV for positive and 2.5 kV for negative ionization modes.
The temperatures of the ion transfer capillary and vaporiser were,
respectively, 342◦ and 258◦C with sheath and auxiliary gas set at
45 and 13 arbitrary units, respectively. The data were acquired
using Thermo Scientific Xcalibur version 4.2.28.14.
Metabolites were annotated to Metabolomics Standards
Initiative (MSI) level 1 (40) by matching masses, MSn and
retention times with authentic standards or with the respective
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TABLE 2 | Summary of data and biological samples collected during Study 2.
Data collected/measures Study time point
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anthropometrics
X
Eligibility criteria (medical history,




One day food diary X X X
Height & waist circumference X
Weight X X X X X X
Food frequency questionnaire X
IPAQ Physical activity questionnaire X X X
Dietary compliance record X X X
Meal time record X X X
Urine samples X X X X X X
Urine sample collection record X X X X X X
Blood sample (plasma, serum & whole
blood)
X X X
IPAQ, International Physical Activity Questionnaire.
aglycone (if the biotransformation product was unavailable). MSI
level 2 structural assignment was achieved by putativelymatching
signal behavior with that of authentic standards reported
in the literature (based upon physicochemical properties,
retention times and spectral similarity) or fragmentation pattern
alignment with data in public/commercial spectral libraries
[Lipid Maps, HMDB, Metlin, and Massbank (41–44)]. MSI level




As shown in Figure 2, 150 people expressed an interest, or
were invited to participate, in the studies over a 10 month
period: 40 people for entry into Study 1 and 116 people for
entry into Study 2 (six people took part in both studies).
Personal details, self-reported anthropometrics, medical history
and lifestyle information (smoking, alcohol consumption, dietary
supplementation) were provided by 70% people (n= 105). More
than 70% of those invited to participate in Study 1 had taken
part in earlier nutrition research studies at Newcastle University
and six were subsequently recruited. A further nine participants
learned about the study through word of mouth. The majority
(85%) of those who expressed an interest in Study 2 and were
screened for eligibility (69%) had learned about it through local
community and internal university advertising and contributed
66% of enrolled participants. The remaining participants had
either taken part in Study 1 (17%) or heard about the study
through word of mouth (17%). The desired sample size (n =
15) was met in Study 1 and the target recruitment (n = 30) was
exceeded by 20% in Study 2.
Baseline Characteristics of Participants
Participants aged 19–77 years (mean 46 years), of whom
57% were female, took part in the studies (Table 3). The
participants were generally healthy: arthritis, previous cancer
and hypertension were the most commonly reported medical
history. Smokers were excluded from the study and while 78%
participants were alcohol consumers, weekly consumption
(median 4.5 units) was well below the recommended maximum
levels. Mean BMI (24.1) was within the normal range but
almost 20% of participants had central obesity. Twenty-five
percent of participants reported taking dietary supplements with
fish oils/cod liver oil being the most commonly consumed
supplement. Self-reported physical activity levels were
relatively high−59% of participants were categorized as
highly physically active according to the IPAQ guidelines
(45). Self-reported sitting time, measured by the IPAQ, was
also high with participants reporting, on average, 6 h sitting
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FIGURE 2 | Flow of participants during recruitment to the MAIN Study. Study 1 preceded Study 2; six participants took part in both studies.
time/day. This exceeds the 4 h sitting time/day cut-off point
considered a proxy for sedentary behavior detrimental to
health (46).
Participant characteristics were similar in both studies
but those recruited to Study 2 were slightly older (mean
1.4 years) and had a lower BMI. They were less likely to
report consuming alcohol, although weekly consumption
amongst those who did was higher (based on self-reported
weekly alcohol intake). Ten percent more participants
were categorized as having central obesity in Study 1 than
in Study 2.
Validation of Study Design for Discovery of
Novel Biomarkers of Dietary Exposure
In recent publications, we have reported that dietary exposure
biomarker discovery was possible within the context of the
present comprehensive food intervention mimicking a typical
UK diet in free-living individuals with minimal intrusion on
normal daily activities (26, 27). Validation of the overall MAIN
Study Newcastle design for efficient biomarker discovery was
assessed initially by confirming the presence of expected BFIs in
urine samples collected during and following experimental day
1 in Study 1 (26). Biomarker performance was further tested
using different food formulations and processing methods with
several types of meat, wholegrains, fruit and vegetables (26).
Additionally it was shown that the urine sampling methodology
for free-living study participants was non-intrusive and delivered
samples with high quality metabolome content using metabolite
fingerprinting (27).
Against this background, we now demonstrate that the MAIN
Study Newcastle design, coupled with metabolomic techniques,
made possible the discovery of new BFIs for use in monitoring
dietary intake in free-living individuals eating conventional diets.
As an example, the schematic of the dietary exposure biomarker
discovery strategy using BFIs of legumes is shown in Figure 3.
Participants were exposed to an evening meal (Figure 3A)
containing a typically consumed legume (garden peas). Random
Forest modeling of metabolite fingerprints representing urines
collected at bed-time following this meal and FMV urine
samples acquired earlier in the day showed that the urine
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TABLE 3 | Characteristics of the MAIN Study participants at baseline.
Study 1 Study 2 Total
Variable Mean (SD) Mean (SD) Mean (SD)
Demographics
Total [n] 15 36 51
Sex
Female [%] 53 58 57
Age [years] 45.3 (14.8) 46.7 (18.7) 46.3 (17.5)
Age range (min-max) [years] 22–63 19–77 19–77
Health Conditions [n]
Arthritis 0 4 4
History of cancer 1 3 4
Hypercholesterolemia 0 1 1
Hypertension 0 4 4
Irritable bowel syndrome 1 0 1
Osteoporosis 0 1 1
Stomach/bowel problems 0 1 1
Diet [n]
Vegetarian 0 1 1
Pescatarian 1 1 2
Food Allergies# 0 2 2
Did not eat pork for religious
reasons
0 1 1
Supplement use 4 9 13
Sport supplementU 1 0 1
Vitabiotics Osteocare6= 1 0 1
Guarana 1 0 1
Ginkgo Biloba 1 0 1
Aloe Vera 0 1 1
Garlic 1 1 2
Evening Primrose oil 1 1 2
Fish oils/cod liver oil 1 6 7
Glucosamine 0 2 2
Chondroitin 0 1 1
Zinc 0 1 1
Cranberry extract 0 1 1
Vitamin D 0 1 1
Vitamin C 0 1 1
Multivitamins 0 1 1
Lifestylea
Alcohol
Consumers [%] 87 75 78




Weight [kg] 71.9 (13.5) 66.8 (10.4) 68.3 (11.5)
Height [cm] 169.5 (9.0) 167.6 (7.7) 168.2 (8.0)
Waist circumference [cm] 84.5 (11.3) 82.5 (9.1) 83.1 (9.7)
BMI [kg m−²]c 24.9 (3.7) 23.7 (3.1) 24.1 (3.3)
Weight Status [%]
Normal 60.0 66.7 64.7
Overweight 33.3 27.8 29.4
Obese 6.7 5.6 5.9
Central Obesityd 26.7 16.7 19.6
(Continued)
TABLE 3 | Continued
Physical Activitye










High 69.2 54.8 59.1
Moderate 30.8 29.0 29.5
Low 0 16.1 11.4






In this table data are presented as mean (standard deviation, SD) for continuous variables
and as number of participants or percentage (%) for categorical variables, except for
alcohol consumption, total physical activity (PA), and sitting time, which are given as
median (interquartile range). MET, metabolic equivalent of task.
asmokers were excluded from the study.
bparticipants who reported no alcohol consumption were excluded from this analysis.
cbody Mass Index (BMI) was calculated as [weight(kg)/height(m)2]. BMI cut-off points
for determination of weight status were: normal weight 18.5–24.9 kgm−2, overweight
25.0–29.9 kgm−2, obese 29.9–39.9 kgm−2.
dcentral obesity was determined using waist circumference as a proxy, with sex-specific
cut-off points (females ≥ 88 cm, males ≥ 102 cm).
eto classify individuals according to their self-reported PA, MET-minutes per week were
calculated and participants were grouped into three activity levels (high, moderate, low)
according to the cut-points defined in the International Physical Activity Questionnaire
(IPAQ) guidelines (45). Outliers were excluded along with datasets of individuals containing
missing values (n = 2). Reported duration of activity was truncated to 180min, where
necessary, according to the IPAQ data processing rules.
f sitting time is defined as a sedentary-related behavior (47) and spending 4 h or more
(≥240min) a day sitting is a proxy measure of sedentary behavior detrimental to
health (46).
#food allergies were to shellfish (1 person) and whole egg/milk (1 person).
Ueach serving contains 150mg of caffeine and 1.7 g creatine monohydrate, plus specific
amino acids, vitamins, fruit extracts, and black pepper extracts.
6=contains calcium, vitamin D, zinc, and magnesium.
samples had very distinctive compositions (Figure 3B). Feature
selection identified several metabolite signals that were strongly
explanatory of compositional differences between these two urine
classes. Further analysis of urine composition after consumption
of a range of legumes (beans, soy and peanuts) in other
MAIN Study Newcastle menu plans revealed several explanatory
metabolites in common, including m/z 204.98143. Detailed
structural analysis indicated that this particular compound is
pyrogallol sulpate (Figure 3C). The large relative increase in the
pyrogallol sulpate signal after consumption of peas in shown in
Figure 3D.
Following an identical rationale, a selection of potential
biomarkers of an extended range of foods is summarized in
Table 4. In addition to pyrogallol sulfate, pyrogallol glucuronide
and trigonelline emerged as generic biomarkers of legume
consumption (beans, peanuts, peas and soy). Eugenol
glucuronide and eugenol sulfate were elevated in urine
after consumption of curry and are potential biomarkers of
this food group. The metabolite, 2-furoylglycine, appeared
discriminatory for high temperature baked foods (e.g.,
pies) and toasted grain products (e.g., toasted bread). We
identified furaneol (sulfate and glucuronide) and mesifurane
after the consumption of strawberries and tomato products.
Higher concentrations of Maillard reaction intermediates
Frontiers in Nutrition | www.frontiersin.org 9 October 2020 | Volume 7 | Article 561010
Willis et al. Dietary Intervention for Biomarker Discovery
2,4-dihydroxy-2,5-dimethyl-3(2H)-furanone (acetylformoine)
in both its sulfate and glucuronide forms and norfuraneol
sulfate (4-hydroxy-5-methyl-3(2H)-furanone) were observed in
urine following consumption of both high temperature-baked
and toasted grain products as well as strawberries, berries
and tomato. After the consumption of a low-calorie beverage,
urinary concentration of the sweetener acesulfame potassium
was elevated for up to 12 h (Table 4).
DISCUSSION
Success of Free-Living Study Design
Our aim was to design and implement a prolonged dietary
intervention study which would allow the collection of urine
samples for biomarker studies in a home or work environment.
Study recruitment achieved (Study 1) or surpassed (Study 2)
original expectations with 51 healthy adults consuming specific
foods and beverages, provided in toto by the research team.
Apart from a visit to the research unit to pick up food at the
beginning, and to deliver urine samples at the end, of each
experimental week, participants were free-living and had the
freedom to eat or not the meals and to interpret the cooking
instructions as they wished. A combination of no drop outs
and high compliance rates with regard to meal consumption (>
80%), suggests that this food intervention strategy was highly
acceptable to participants [see Lloyd et al. (27) for details
on compliance].
Participants collected urine samples within pre-specified time
frames each day and fasting blood samples were collected in
the morning of the final (“Post”) day of each experimental
week. This aspect of the study was designed to be as minimally
intrusive as possible to investigate the potential for such
urine collections to be incorporated into future larger-scale
epidemiological studies and surveys. Data associated with urine
collection has been described in a recent publication (27) and
indicated that the most successful urine type collected within this
cohort was the FMV and the post-dinner spot sample (both at
99% compliance). The fasting sample was the least successfully
collected sample. Evidence that the urine sampling methodology
imposed low burden on participants and delivered samples with
high quality metabolome content has been published (27). From
a metabolomics perspective, the overall experimental design was
validated by confirming the presence of known BFIs in urine
samples after exposure to menu plan 1 (26).
Discovery of Novel Exposure Biomarkers
For BFIs to have utility in assessing dietary intake as a
whole, it is essential that the dietary exposure biomarker
panel is as comprehensive as possible. To date, the focus on
BFI discovery has centered largely on healthy foods of high
public health significance (50, 51) rather than more unhealthy
foods containing high levels of fat, sugar and salt (52–54).
We used our intervention design in a free-living population
to aid the discovery of novel biomarkers to help complete
coverage of the UK Eatwell Guide (25) whilst aiming to monitor
comprehensively both the whole diet and the range of cooking
methods used in populations.
UK government policy recommends the consumption
of more beans and pulses and less red and processed meat
(25). However, there is very limited data on potential
urinary biomarkers for non-meat protein-rich foods, such
as beans, lentils, and other pulses (55, 56). Here we propose
pyrogallol sulfate and glucuronide as potential markers of overall
legume consumption (beans, peanuts, peas, soy). Additionally,
trigonelline, despite being well-documented as a coffee (57) and
pea consumption biomarker (58), and most recently, a novel
candidate marker for soy (59), is, in fact, a general legume BFI.
However, whilst potential BFIs for legumes, these markers are
not exclusive to pulses. Pyrogallol is present in low quantities
in beer (60), cocoa and coffee and is excreted as a sulfate after
green tea and nut consumption (61, 62). These findings illustrate
the need to utilize urine samples from a comprehensive food
intervention to investigate specificity to individual foods or
food groups. If the dietary source(s) of trigonelline needed to be
identified further, then the relative contribution of coffee and soy
consumption could be estimated using additional discriminatory
biomarkers such as caffeine and daidzein sulfate, respectively
(57, 63). These biomarkers could be added to a panel of BFIs
to monitor protein-rich food intake, together with anserine
and TMAO (Trimethylamine-N-oxide) to indicate poultry and
fish intake and carnitine and carnosine to indicate red meat
consumption (16, 64).
It still remains challenging to assess the overall “quality”
of meat products that are consumed since processed meat
products have very variable levels of striated muscle content
(19, 65). However, it is possible that BFIs of meal components
strongly associated with generally unhealthy diet patterns (66)
such as a deep fried-potato (22) or mechanically recovered
meat could be highly informative (19, 65). These issues will
need to be addressed in the future to provide a comprehensive
panel of biomarkers that can characterize and quantify eating
habits in toto.
Concentrations of eugenol glucuronide and eugenol sulfate
in urine increased after the consumption of curry possibly
because clove (a common component of curry) is rich in
eugenol (67). Having biomarkers that provide information
about the cooking and processing methods used with foods
would be an important addition to biomarkers that reflect
the raw ingredients of the dish/meal because different cooking
methods can change the quality and therefore healthiness of
a food. Obtaining this level of information can be difficult
using self-reported dietary assessment instruments, especially
widely-used food frequency questionnaires. To date, a few
such biomarkers of high-temperature cooked meats have
been described (68). In the present study, the marker 2-
furoylglycine appeared discriminatory for thermally treated
foods including pies, grains and toasted wheat products
(e.g., toasted bread). This marker has been described as
an acute coffee consumption biomarker (69) which results
from furan metabolites that arise through roasting of coffee
beans via the Maillard reaction. Our metabolomics approach
identified several other thermally treated/heated food Maillard
products—furanones—including 2,4-dihydroxy-2,5-dimethyl-3-
furanone sulfate and glucuronide and norfuraneol sulfate,
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FIGURE 3 | Schematic of the dietary exposure biomarker discovery strategy within the context of a comprehensive food intervention mimicking a typical UK diet in
free-living individuals. (A) Meal items consumed at Dinner time on Menu plan 3 [details in Lloyd et al. (27)]; (B) Multi-dimensional scaling (MDS) of Random Forest (RF)
proximity values of the FIE-HRMS urinary fingerprint data of first morning void and bed-time urines from the same day that Menu plan 3 was consumed; (C)
Annotation of a metabolite signal highly explanatory of legume exposure on several experimental days when legumes were included on the menu; (D) Box-plots
showing the association between pea consumption and the relative intensity of the pyrogallol sulfate signal [M-H]1− in urine samples taken throughout the day that
Menu plan 3 was eaten.
which have been detected as aglycones in bread crust and
popcorn, respectively (70, 71), but not reported previously in
urine samples. 2,4-dihydroxy-2,5-dimethyl-3-furanone sulfate
and glucuronide have been reported as markers for the intake
of deep-fried potatoes, but, due to their presence in other
foods, these compounds are not likely to be specific (22).
Although furanones are formed by the Maillard reaction
during the thermal treatment of food, they can also be
biosynthesized by plants, microorganisms, and insects [as
reviewed by Slaughter (72)]. Other metabolites structurally
identical to Maillard products, including furaneol and its methyl-
ether derivative mesifurane, are well-documented natural aroma
components in fruits such as pineapple, raspberry, mango,
grapefruit, tomato, and strawberry (73) and the glucuronide
and sulfate of these compounds have been reported in urine
after strawberry consumption (48, 74). In the current study,
we confirmed this observation and suggest that furaneol
glucuronide and sulfate, and mesifurane sulfate, are generic
biomarkers of berry and tomato consumption (Table 4).
Assessment of the relative concentrations of some of these
chemicals and strawberry/berry/tomato specific compounds
{i.e., pelargonidin [strawberry], hydroxyphenylvalerolactone
[procyanidin-rich food (75)] and lycopene in plasma for tomato
(76)}, could provide rich information on cooking methods
and could, potentially, distinguish between berry fruit and
tomato consumption.
Foods high in added sugar are not needed in the diet
and should only be consumed in very small amounts (25).
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TABLE 4 | Discovery of novel biomarkers for foods where biomarkers have yet to be discovered in relation to UK Public health policies.




Pyrogallol (1,2,3-Trihydroxybenzene) sulfate [M-H]1−, [M-H]1− 13C, [M-H]1− 34S 1
Trigonelline [M+H]1+13C, [M+Na]1+, [M+Na]1+ 13C,
[M+K]1+, [M+K]1+13C, [M+K]1+41K
1
Curry (clove) Eugenol glucuronide [M-H]1−, [M-H-gluc]1−, [M-H-gluc]1−13C 1
Eugenol sulfate [M-H]1−, [M-H]1−34S 1
High temperature baked and toasted grain products 2-Furoylglycine [M+Na]1+, [M+K]1+, [M+2Na-H]1+,
[M+KNa-H]1+, [M-H]1−
1
Strawberry, berries, and tomato Furaneol sulfate [M-H]1−, [M-H]1−13C, [M-H]1−34S 1




[M-H]1− 2 (48, 49)
High temperature baked and toasted grain products










Low calorie drinks Acesulfame potassium [M-K]1−, [M-K]1−13C, [M-K]1−34S 1
MSI level 1, matching masses, MSn and retention times with authentic standards or with the respective aglycone; MSI level 2, structural assignment achieved by putatively matching
signal behavior with that of authentic standards reported in the literature or fragmentation pattern alignment with data in public/commercial spectral libraries; MSI level 3, structural
identification indicated a putatively characterized compound class.
Urinary sucrose has previously been shown to be a marker
of acute sugar exposure (53) and appeared discriminatory of
the consumption of high sugar products, such as sweetened
breakfast cereals, in the present study (26). Many food
manufacturers are now substituting sugars in traditionally
sugar-sweetened beverages with low-calorie sweeteners, to help
combat risks associated with high sugar intake (77). The
urinary concentration of the sweetener acesulfame potassium
was elevated after the consumption of a low-calorie beverage
and remained so for up to 12 h after consumption (Table 4).
This low-calorie sweetener is a known component of the
chosen beverage and, in addition to other commonly consumed
sweeteners, is a potential biomarker of recent low-calorie
beverage intake (78).
Strengths and Limitations of Study Design
The MAIN Study Newcastle is one of the largest food
interventions reported to date using metabolomics approaches
to discover new, and to help validate existing, biomarkers of
foods frequently consumed in the UK. A key objective was
to design an efficient and acceptable intervention strategy that
would expose study participants to foods encountered commonly
in the UK diet. We established a successful food exposure
strategy using information on consumption frequencies, food
groupings and eating habits from the UK NDNS data (31)
together with Public Health England policy advice (25) using
standard portion sizes (32). We demonstrated that it is possible
to design menus that mimic major features of a typical UK
diet and are suitable for short-term randomized controlled
dietary interventions “experimental periods” lasting only 3 days.
Importantly each experimental period contained menu plans
organized to emulate conventional UK eating patterns with
a breakfast, lunch, afternoon snack and dinner that differed
each day. This intervention strategy may be of value for the
design of future studies of BFI discovery and validation in
other populations globally. This design differs from many other
reported biomarker discovery studies that utilized either single
meals/ingredients in isolation (15, 30, 79, 80) or repeated menus
(81) or depended on supplementation of the habitual diet
(82, 83). Additionally, the overall menu design ensured that
participants were exposed to several formulations of individual
foods. In other work within the MAIN project, we have
demonstrated the value of spot urines for assessing dietary
intake (29). The present protocol required all study participants
to store 20ml urine samples in their home fridges for up
to 5 days before transporting them to the research unit at
the end of each experimental week. We have checked that
urine samples collected at home and stored at 4◦C are stable
and not subject to microbial degradation (36). When outside
the home, small cool bags were supplied for temporary urine
storage. All urine spot samples were collected with success rates
exceeding 90% showing that this approach to urine sampling
for biomarker studies is highly acceptable. Additionally, the
collection of multiple spot urines allowed us to investigate
systematically the utility of home collected spot urine samples
taken at various times in the diurnal feeding and fasting cycle
for BFI discovery [see Lloyd et al. (27)]. Based on these
observations we suggest that the protocols used in the MAIN
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study have overcome many of the design challenges summarized
in Table 1.
From a biomarker discovery perspective, an important finding
from Study 1 was that the consumption of a standardized
evening meal prior to the experimental period had little impact
on the ability to discover BFIs [see Lloyd et al. (26)]. This
finding simplified the design of the wider food intervention
in Study 2 and reduced the burden on the study participants
by requiring only a limit on the consumption of polyphenol-
rich foods prior to each experimental period. Furthermore,
the characteristics of the MAIN study participants (Table 3)
in respect of sex, age, adiposity, physical activity and general
health indicate that BFIs discovered in this study are likely to
be generalizable to the wider population. Importantly, in the
MAIN Study Newcastle, all foods and beverages were prepared
and consumed by free-living participants in their own homes
rather than in a controlled clinical facility (24). This strategy
ensured that metabolomic analyses were undertaken within
the context of normal eating behaviors and in real world
meal patterns, rather than following consumption of discrete
items in isolation. In addition, this study design took into
account the inherent variability associated with unsupervised
individuals preparing meals and eating them in their own
homes and collecting urine samples within flexible time ranges.
Importantly, the comprehensiveness of this food intervention
provides opportunity to examine the specificity of putative
biomarkers in relation to exposure to a wide range of foods within
the same biobank of samples.
Although the MAIN study had great value for the discovery
of putative BFIs, some sources of variability were not considered.
For example, the study employed relatively healthy individuals
and we excluded those with current disease or disease treatment
which might have altered the metabolism of ingested foods. As
a consequence, future studies should explore the robustness of
biomarkers of food intake in population groups with poorer
health, particularly those who are taking prescribed medications
that affect the P450 enzyme consortium or the gut microbiome.
Our cohort of participants included one individual with irritable
bowel syndrome (IBS)—contrary to the study inclusion criteria—
but it seems unlikely that this would have had a major effect
on the overall findings. Similarly, our cohort included three
participants who were slightly obese (BMI 32.2–33.0 kg/m2)
and, again, it is unlikely that this infringement of the exclusion
criteria will have affected the findings. It is possible also
that participant genotype will alter the pattern of metabolites
produced from a given food constituent and so for this reason
further work should investigate the impact of common variants
in the genes encoding Phase 1 and Phase 2 enzyme systems,
an example being the P450 consortium (14), on urinary BFIs.
It should be noted that several of the putative BFI reported
here are biotransformation products (sulfates and glucuronides)
that could be identified to the level of the aglycone only (i.e.,
pyrogallol, eugenol, furaneol), because chemical standards for
the biotransformed products are not available commercially at a
reasonable cost.
Future Work
In previous publications, we have shown that when using a
combination of non-targeted metabolite profiles and targeted
BFIs for assessment of dietary patterns, spot samples are suitable
replacements for 24-h urine samples (29). The collection of
multiple spot urine samples throughout the day using a home
urine sample collection method will enable us to determine
which samples (e.g., FMV or bed-time) or combinations thereof,
and how many samples, are optimal for assessment of eating
behavior using BFIs. It is anticipated that multiple, well-
spaced spot samples collected over several weeks would be
able to capture biomarker data accurately, reflecting habitual
exposure to a wide range of food groups in a similar way
to that achieved using multiple 24 h recall methods. The
ultimate aim of our studies is to deploy a comprehensive
BFI panel to aid in monitoring habitual dietary exposure
in clinical trials or population surveys at a range of scales.
With this aim in mind, we have developed methodology for
urine collection using vacuum transfer technology which is
suitable for routine use and may provide a scalable, cost-
effective means to collect urine samples and to assess dietary
intake in large-scale epidemiological studies and in public health
surveys (36).
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